Literature DB >> 8700363

Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure.

H Neveu1, D Kleinknecht, F Brivet, P Loirat, P Landais.   

Abstract

BACKGROUND: Sepsis is a major cause of acute renal failure in hospital patients, but its incidence and the associated prognostic factors have rarely been assessed prospectively by multivariate analysis.
METHODS: We conducted a prospective 6-month study in 20 multidisciplinary intensive care units to assess the prognosis of patients hospitalized with acute renal failure due to sepsis. Sepsis syndrome and septic shock were defined according to the criteria of the Society of Critical Care Medicine Consensus Conference. Severity scoring indexes (SAPS, APACHE II, and organ system failure (OSF)) were measured on ICU admission and on inclusion. The end-point was hospital mortality.
RESULTS: Acute renal failure had a septic origin in 157 patients (Group 1), comprising 68 with septic shock and 89 with sepsis syndrome, and did not result from infection in 188 patients (Group 2). Patients with septic acute renal failure were older (mean age: 62.2 versus 57.9 years, P<0.02) and had on inclusion a higher SAPS (19.3 versus 16.1, P<0.001), APACHE II (29.6 versus 24.3, P<0.001), and OSF (2.07 versus 1.52, P<0.001) than patients with non-septic acute renal failure. They had a higher need for mechanical ventilation (69.1% versus 47.3%, P<0.001), and acute renal failure was more often delayed during the ICU stay than was present on admission (47.7% versus 32.4% respectively, P<0.005). Hospital mortality was higher in patients with septic acute renal failure (74.5%) than in those whose renal failure did not result from sepsis (45.2%, P<0.001). Mortality was influenced by the presence of a septic shock (79.4%) or of a sepsis syndrome on inclusion (70.8%). Using a stepwise logistic regression model, sepsis was an independent predictor of hospital mortality (OR, 2.51; 95% CI, 1.44-4.39) as well as a delayed occurrence of acute renal failure, oliguria, an altered previous health status hospitalization prior to ICU, need for mechanical ventilation, age and severity scoring indexes on inclusion. In total patients, mortality was higher in dialyzed than in non-dialyzed patients (P<0.001), and in those treated by continuous compared to intermittent techniques (P<0.01). Patients dialyzed with biocompatible membranes had a lower mortality than those treated with cellulose membranes (P<0.005).
CONCLUSIONS: Patients with acute renal failure due to sepsis have a worse prognosis than those with non-septic acute renal failure. Sepsis and the above-defined predictive factors are to be considered in studies on prognosis of ARF patients. Our results suggest that the use of biocompatible membranes may reduce significantly mortality in these patients.

Entities:  

Mesh:

Year:  1996        PMID: 8700363     DOI: 10.1093/oxfordjournals.ndt.a027256

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  65 in total

Review 1.  Acute kidney injury in the intensive care unit.

Authors:  Petar Kes; Nikolina Basić Jukić
Journal:  Bosn J Basic Med Sci       Date:  2010-04       Impact factor: 3.363

Review 2.  The role of Toll-like receptors in renal diseases.

Authors:  Anna Gluba; Maciej Banach; Simon Hannam; Dimitri P Mikhailidis; Agata Sakowicz; Jacek Rysz
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 3.  Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis.

Authors:  B Rochwerg; W Alhazzani; A Gibson; C M Ribic; A Sindi; D Heels-Ansdell; L Thabane; A Fox-Robichaud; L Mbuagbaw; W Szczeklik; F Alshamsi; S Altayyar; W Ip; G Li; M Wang; A Włudarczyk; Q Zhou; D Annane; D J Cook; R Jaeschke; G H Guyatt
Journal:  Intensive Care Med       Date:  2015-04-23       Impact factor: 17.440

Review 4.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

5.  The multiple organ dysfunction syndrome and late-phase mortality in sepsis.

Authors:  Joshua A Englert; Mitchell P Fink
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

6.  Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness.

Authors:  Sean M Bagshaw; Michael Bennett; Michael Haase; Anja Haase-Fielitz; Moritoki Egi; Hiroshi Morimatsu; Giuseppe D'amico; Donna Goldsmith; Prasad Devarajan; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2009-12-03       Impact factor: 17.440

7.  Long-term risk of mortality after acute kidney injury in patients with sepsis: a contemporary analysis.

Authors:  José António Lopes; Paulo Fernandes; Sofia Jorge; Cristina Resina; Carla Santos; Alvaro Pereira; José Neves; Francisco Antunes; António Gomes da Costa
Journal:  BMC Nephrol       Date:  2010-06-02       Impact factor: 2.388

8.  AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality.

Authors:  K Doi; X Hu; P S T Yuen; A Leelahavanichkul; H Yasuda; S M Kim; J Schnermann; T E N Jonassen; J Frøkiaer; S Nielsen; R A Star
Journal:  Kidney Int       Date:  2008-03-19       Impact factor: 10.612

Review 9.  Urinary biomarkers in septic acute kidney injury.

Authors:  Sean M Bagshaw; Christoph Langenberg; Michael Haase; Li Wan; Clive N May; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2007-05-09       Impact factor: 17.440

Review 10.  Acute kidney injury in the elderly.

Authors:  Khaled Abdel-Kader; Paul M Palevsky
Journal:  Clin Geriatr Med       Date:  2009-08       Impact factor: 3.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.